Defects in L/R asymmetry arise in 1/10,000 humans[@R6], and the associated morbidity and mortality usually imply congenital heart defects (CHDs)[@R6],[@R7]. The EMT converts epithelial cells into migratory cells, and it is required in tissues and organs generated after profound cell movements, such as the mesoderm and the neural crest[@R8]. Thus, L/R asymmetries and EMT provoke severe congenital malformations or early embryonic lethality when deregulated[@R1],[@R9].

After an initial disruption of L/R symmetry in the vertebrate embryo, laterality is conferred to the organizer (node) and this information is transferred to the left LPM[@R1]. The left-specific programme in the LPM is driven by Nodal and its downstream target Pitx2. This pathway is conserved in deuterostomes, and in chick and mouse embryos it is repressed on the right-hand side by the EMT inducer Snail1[@R3],[@R4]. We have found that like Snail1 in amniotes, a *prrx1* gene duplicate (*prrx1a)*, is transiently expressed in the zebrafish embryo LPM with higher levels on the right ([Fig. 1a](#F1){ref-type="fig"}). Prrx1, like Pitx2, is a paired-like homeobox transcription factor, and like Snail1, is an EMT inducer in embryos and cancer cells[@R10].

In vertebrates, the convergence of the left and right cardiogenic regions in the embryonic midline results in the formation of a linear primary heart tube (PHT). The subsequent bilateral addition of progenitor cells to the arterial (anterior) and venous (posterior) poles from the corresponding second heart fields (SHFs), respectively contribute to the elongation and growth of the heart at the outflow (OFT) and inflow (IFT) tracts [@R11]. These additions occur at the time of heart looping, for which the underlying mechanisms remain poorly understood[@R11] although defects in the posterior pole are responsible for numerous CHDs in humans. Considering Prrx1a L/R asymmetric expression and its described role in the induction of cell movements[@R10], we examined whether *prrx1a* knockdown influenced heart situs. Both *prrx1a* morpholino oligonucleotide (*prrx1a*^MO1^ or *prrx1a*^MO2^)[@R10] injections or CRISPR/Cas9-driven *prrx1a* mutations led to mesocardia, a straight heart that failed to undergo the normal dextral looping ([Fig. 1b, c](#F1){ref-type="fig"} and [Extended Data Fig. 1](#F6){ref-type="fig"}). Both atrial and ventricular chambers are specified in the morphants ([Fig. 1d](#F1){ref-type="fig"}), but, in addition to defective looping, the heart presented,a smaller atrium and a defective posterior pole lacking a defined *sinus venosus* (SV) and the expression of its marker Islet1[@R12],[@R13] ([Fig. 1e](#F1){ref-type="fig"} and [Extended Data Fig. 2a-c](#F7){ref-type="fig"}). However, the anterior pole was not overtly affected ([Extended Data Fig. 2d](#F7){ref-type="fig"}).

As Tbx5a is a transcription factor expressed in the PHT and in the LPM cells that contribute to the pericardium and the posterior pole[@R14],[@R15], we generated a *tbx5a* reporter transgenic line *tg(tbx5a:eGFP)* that allowed us to see its coexpression with Prrx1a in the precursors of the posterior pole once the PHT had been formed ([Extended Data Fig. 3](#F8){ref-type="fig"}) and to follow the movements and fate of this population of Prrx1a^+^ cells. Cell tracing experiments in this area using the photoconvertible (Pc) green-to-red Kaede potein indicated that Prrx1a^+^cells contributed to both the pericardium and the atrium, explaining the defective atrium in the *prrx1a* morphants ([Fig. 2a](#F2){ref-type="fig"}). These atrial cells do not express Prrx1 any longer, indicating that *prrx1a* is downregulated after incorporation into the heart. As such, Prrx1 protein was never observed in the heart tube, positive for *tbx5a* ([Fig. 2a](#F2){ref-type="fig"} and [Extended Data Fig. 4a-d](#F9){ref-type="fig"}). Notably, other embryonic and cancer cells also downregulate EMT transcription factors, including *Prrx1,* when they lose their mesenchymal nature and undergo differentiation upon reaching their final destination[@R8].

We also followed the cell movements towards the posterior pole and found that they were defective in the morphants concomitantly with the failure of heart looping ([Fig. 2b](#F2){ref-type="fig"} and [Supplementary Videos 1](#SD3){ref-type="supplementary-material"} and [2](#SD5){ref-type="supplementary-material"}). We detected actomyosin stress fibers in Prrx1^+^ cells, which also showed elongated cell shape and nuclei. These phenotypic traits, when associated with cell movements, are characteristic of mesenchymal cells undergoing EMT ([Fig. 2c](#F2){ref-type="fig"} located in area boxed in [Fig. 2b](#F2){ref-type="fig"}), which were absent in morphant embryos. In turn, morphants showed numerous *tbx5a^+^* positive cells that failed to contribute to the posterior pole and the atrium, remaining dispersed throughout the pericardium ([Extended Data Fig. 5a](#F10){ref-type="fig"}), again explaining their defective posterior pole ([Fig. 1e](#F1){ref-type="fig"} and [Extended Data Fig. 2a-c](#F7){ref-type="fig"}). Altogether, this indicates that Prrx1a might direct Tbx5a^+^ cardiac progenitors to the posterior pole in a bilaterally asymmetric manner, with a greater contribution from the right.

Directed cell migration has already been implicated in heart jogging, an initial leftward displacement of the PHT driven by Nodal in zebrafish[@R16],[@R17]. While we found randomization of heart jogging in *prrx1a* morphants ([Extended Data Fig. 5b, c](#F10){ref-type="fig"}), the majority of embryos developed mesocardia regardless of the direction of jogging ([Supplementary Videos 3](#SD6){ref-type="supplementary-material"} and [4](#SD7){ref-type="supplementary-material"}), indicating that the Prrx1-mediated driving force for heart looping occurs at later stages, compatible with looping being independent of both jogging and the Nodal pathway[@R16],[@R18].

The asymmetric contribution of right and left cells may generate asymmetric forces and greater tension on the right-hand side, inducing a maintained leftward displacement of the posterior pole that would promote the dextral torsion of the heart[@R19]--[@R21], the two steps in looping morphogenesis. Compatible with this, the *tbx5a* reporter revealed cells that appeared to form a structure reminiscent of a cable ([Fig. 2d](#F2){ref-type="fig"}). To assess the contribution of asymmetric tension to heart looping, we laser ablated a small population of *tbx5a*^+^/prrx1a^+^ LPM cells adjacent to the PHT on either side after jogging and before looping. Heart lateralization was only affected after ablating cells in the right LPM ([Fig. 2e](#F2){ref-type="fig"} and [Extended Data Fig. 6a-c](#F11){ref-type="fig"}). *In vivo* visualization of actin stress fibers and actin/myosin double labelling confirmed the formation of a cable during looping, a structure that was absent in *prrx1*a morphants ([Fig. 2f](#F2){ref-type="fig"}, [Extended Data Fig. 6d, e](#F11){ref-type="fig"} and [Supplementary Videos 5](#SD8){ref-type="supplementary-material"} to [8](#SD11){ref-type="supplementary-material"}).

We next found that Palladin, an actin-binding protein that promotes actin bundling in migratory and invasive cells[@R22],[@R23] was co-expressed with Prrx1 and *tbx5a* in the cable-like structure*,* and downregulated in the *prrx1a* morphants ([Fig. 2g](#F2){ref-type="fig"}), linking Prrx1 with the cytoskeleton. This actomyosin cable is reminiscent of those that control forces during embryonic development[@R24],[@R25]. Its function during looping is compatible with the mesocardia found when zebrafish PHT explants[@R18] or embryos were exposed to the myosin inhibitor blebbistatin ([Extended Data Fig. 6f](#F11){ref-type="fig"} and [Supplementary Videos 9](#SD12){ref-type="supplementary-material"} and [10](#SD4){ref-type="supplementary-material"}) and when chick embryos were treated with cytochalasin to inhibit actin polymerization[@R26], suggesting that this mechanism may be conserved in the chick.

A transient asymmetric distribution of *Prrx*1 was evident in the chick LPM, with higher levels on the right-hand side ([Fig. 3a](#F3){ref-type="fig"}) at stages in which *Snail1* is also asymmetrically expressed ([extended Data Fig. 7a](#F12){ref-type="fig"} and Ref. [@R27]). *Prrx1* was also asymmetrically expressed in the *sinus venosus* horns (SH, [Fig. 3b](#F3){ref-type="fig"}). As in the fish, *Prrx1* is not expressed in the cardiac folds (CF) or PHT, but it is expressed by the population of Tbx5^+^ cells lateral and posterior to the cardiac posterior pole ([Extended Data Fig. 7b-d](#F12){ref-type="fig"}). Bilateral downregulation of Prrx1 in the chick embryo induced mesocardia in the majority of embryos ([Fig. 3c](#F3){ref-type="fig"} and [Extended Data Fig. 7e, f](#F12){ref-type="fig"}). However, Prrx1 unilateral downregulation on the left half did not affect heart looping ([Fig. 3d](#F3){ref-type="fig"} and [Extended Data Fig. 7g](#F12){ref-type="fig"}), whereas overexpression could induce reverse looping ([Fig. 3e](#F3){ref-type="fig"} and [Extended Data Fig. 7h](#F12){ref-type="fig"}), further evidence that Prrx1 L/R asymmetric expression drives heart laterality.

As in the zebrafish embryo, deficient Prrx1 expression did not prevent the specification of atrial and ventricular fates, the size of the atrium was reduced and did not seem to affect the anterior pole (see OFT) ([Extended Data Fig. 7i-k](#F12){ref-type="fig"}). Again, Islet1 colocalized with Prrx1 in the posterior pole and its expression was downregulated in embryos electroporated with *Prrx1* RNAi ([Fig. 3f](#F3){ref-type="fig"} and [Extended Data Fig. 7l](#F12){ref-type="fig"}). This population of *sinus venosus* progenitors expressing *Tbx18* ([Extended Data Fig. 8a](#F13){ref-type="fig"}), contributes to the posterior pole together with the SHF, and has been referred to as posterior SHF[@R20],[@R28] or tertiary heart field[@R29], because it is located more laterally than the classical *Nkx2.5+* SHF. Interestingly, *Tbx18* is repressed when *Prrx1* is downregulated ([Extended Data Fig. 8b](#F13){ref-type="fig"}). Actin fibers were observed in a cable-like structure of *Prrx1+* cells at the wall of the right vitelline vein (VV) and right *sinus venosus* horns in control embryos ([Extended Data Fig. 8c](#F13){ref-type="fig"}), compatible with the displacement of the posterior pole to the left side. The loss of Phalloidin staining and L/R morphological asymmetry after Prrx1 silencing ([Extended Data Fig. 8c](#F13){ref-type="fig"}) explains the mesocardia observed. The role of actomyosin is confirmed by the mesocardia obtained after incubation with blebbistatin ([Extended Data Fig. 8d](#F13){ref-type="fig"}). As in the fish, Prrx1 downregulation also decreased *Palladin* expression*,* which was coexpressed with *Prrx1* in a L/R asymmetric manner in control embryos ([Fig. 3g](#F3){ref-type="fig"} and [Extended Data Fig. 8e, f](#F13){ref-type="fig"}).

We next investigated the signals that induce *Prrx1* expression and how Prrx1 is integrated into the pathways involved in L/R asymmetry. BMP induces *Prrx1* and *Snail1* expression in the chick embryo[@R10], and the latter represses *Pitx2* transcription on the right-hand side[@R1],[@R3],[@R4]. Administration of BMP4 on the left or its inhibitor Noggin on the right LPM, respectively induced or repressed *Prrx1* expression ([Fig. 4a](#F4){ref-type="fig"}). Ectopic Nodal expression on the right downregulated *Prrx1* expression ([Fig. 4b](#F4){ref-type="fig"} and [Extended Data Fig. 8g](#F13){ref-type="fig"}), and incubation with a Nodal inhibitor increased *Prrx1* levels ([Fig. 4c](#F4){ref-type="fig"}), as previously shown for *Snail1*[@R30]. Noggin can still decrease *Prrx1* levels in the presence of Nodal inhibitor ([Fig. 4c](#F4){ref-type="fig"}), suggesting that the BMP pathway controls Prrx1 expression directly. As such, BMP4 beads on the left side reversed both *Prrx1* L/R asymmetric expression and heart looping ([Fig. 4a](#F4){ref-type="fig"} and [Extended Data Fig. 8h](#F13){ref-type="fig"}). The *Prrx1* gene contains two consensus-binding sites (P and D) for the BMP downstream effectors Smad 1/5/8 ([Extended Data Fig. 8i](#F13){ref-type="fig"}), and Smad5 binds to both ([Extended Data Fig. 8j](#F13){ref-type="fig"}), compatible with its proposed role in heart looping in the mouse[@R31]. The activity of *Prrx1* promoter increases upon BMP4 administration only when these binding sites are intact ([Extended Data Fig. 8k](#F13){ref-type="fig"}). Thus, BMP signalling directly activates *Prrx1* gene transcription.

Incubation of whole zebrafish embryos with BMP4 or Noggin, respectively enhanced or diminished *prrx1a* expression, and Nodal inhibition abolished *prrx1a* L/R asymmetry by de-repressing Prrx1a on the left-hand side of the embryo ([Fig. 4d](#F4){ref-type="fig"}). Hence, BMP-mediated *Prrx1* expression is stronger on the right-hand side to drive normal heart looping, as this right pathway is downregulated on the left-hand side by Nodal both in fish and chick embryos. Thus, two parallel and mutually repressed pathways driven by two TGF-β superfamily members (Nodal and BMP), activate paired-like homeobox transcription factors, Pitx2 and Prrx1 respectively, integrating left-right information ([Fig. 4e](#F4){ref-type="fig"}).

As Snail1 has also been implicated in heart laterality[@R1],[@R3], we examined *Prrx1* and *Snail1* in the chick and both are expressed in the SH with higher levels on the right, covering mutually exclusive territories in lateral mesoderm ([Fig. 5a](#F5){ref-type="fig"} and [Extended Data Figs. 9a](#F14){ref-type="fig"} and [10a](#F15){ref-type="fig"}). Snail1 downregulation with Snail1^MO^ reproduced the effects described[@R3], provoking 26,4% mesocardia and 15,7% L-loop ([Extended Data Fig. 9 b-d](#F14){ref-type="fig"}). Simultaneous downregulation of *Snail1* and *Prrx1* induced mesocardia (50%) with a distribution similar to that found after *Prrx1* downregulation ([Extended Data Fig. 7f](#F12){ref-type="fig"} and [Fig. 9b-d](#F14){ref-type="fig"}). Hence, Snail1 contributes to heart positioning in the chick acting independently from Prrx1, which induces mesocardia independently from Snail1 function.

In the fish embryo, neither *snail1a* nor *snail1b*, result of the teleost whole genome duplication[@R32], showed asymmetric L/R expression ([Extended Data Figs. 9e, f](#F14){ref-type="fig"} and [10a](#F15){ref-type="fig"}), being therefore unlikely that they regulate heart positioning. This was confirmed in morphant embryos ([Extended Data Fig. 9g-i](#F14){ref-type="fig"}). This lack of L/R asymmetry also suggests that, unlike in chick and mouse[@R3],[@R4]~,~ snail1 may not repress *pitx2c* on the right-hand side of the fish. However, *prrx1a* is expressed in the equivalent territories and we found that *pitx2c* was derepressed on the right hand side of the *prrx1a* morphant embryos ([Fig. 5b](#F5){ref-type="fig"}).

*Prrx1* or the *Prrx1/Prrx2* compound mutant mice do not show any overt heart looping defect[@R33],[@R34], compatible with their absence in the territories relevant to heart looping ([Fig. 5c](#F5){ref-type="fig"} and [Extended Data Fig. 10a, b](#F15){ref-type="fig"}). Interestingly, the asymmetric expression of *Prrx1* in the SH in chick embryos is replaced by that of *Snail1* in the mouse (arrows in [Fig. 5a and c](#F5){ref-type="fig"}, and [Extended Data Fig. 10a](#F15){ref-type="fig"}), where actin stress fibers concentrate ([Fig. 5d](#F5){ref-type="fig"}), explaining the heart laterality defects in *Snail1* mutant mice[@R4]. We next depleted Snail1 after early gastrulation stages (see [Methods](#S1){ref-type="sec"}) and found that mutant cells (red) do not accumulate actin fibers ([Fig. 5e](#F5){ref-type="fig"}) and *Palladin* transcription was downregulated ([Fig. 5f](#F5){ref-type="fig"}), confirming that the cellular and molecular pathway observed downstream of Prrx1 in the fish and the chick, operates in the mouse downstream of Snail1.

We provide here evidence of an asymmetric L/R EMT process that drives differential cell movements towards the midline to induce the leftward displacement of the posterior pole of the heart and subsequent dextral looping in vertebrates. The EMT is triggered by different transcription factors in distinct groups, Prrx1a in the zebrafish, Prrx1 and Snail1 in the chick and Snail1 in the mouse. The interchange in some expression sites of *Prrx1* and *Snail1* between chick and mouse is reminiscent of that observed for *Snail1* and *Snail2* in other migratory embryonic territories[@R35], indicating that the use of different EMT inducers for similar processes in different species is not unique to heart laterality, and that an evolutionarily conserved role for EMT in the control of heart positioning operates from fish to mice ([Fig. 5g](#F5){ref-type="fig"} and [Extended Data Fig. 10c](#F15){ref-type="fig"}). In the mouse, Snail1 not only represses left-handed information on the right[@R3],[@R4], but it also instructs the right-handed pathway leading to heart looping. Similarly, Prrx1a fulfills both roles in the zebrafish ([Extended Data Fig. 10d](#F15){ref-type="fig"}). In summary, while a well-described left-hand side Nodal-Pitx2 pathway promotes and stabilizes left identify[@R1], a BMP pathway operates prominently on the right not only to repress the Nodal-Pitx2 pathway, but to provide instructive information that drives heart looping and morphogenesis.

While the Nodal-Pitx2 axis is not conserved in worms and flies, the BMP-Prrx1 pathway activates actomyosin, and myosin acts as a L/R determinant in *Drosophila*[@R36], suggesting a conserved role in laterality during bilaterian evolution. Whether the unilateral leftward cell movement that breaks bilateral symmetry in the early chick embryo is also driven by a similar mechanism awaits further investigation[@R37]. Heart looping is essential for both atrio-ventricular and heart-vasculature concordance[@R7], and hence, for proper organ function. Defining the events underlying this process may shed light on the evolution of the heart from the simple straight invertebrate tube acting as a peristaltic pump to a suction pump in zebrafish and a rhythmically beating structure in amniotes. These data should also help to better understand the CHDs derived from disrupted heart laterality in humans.

Methods {#S1}
=======

Embryos {#S2}
-------

Zebrafish strains AB wild-type, *Tg*(*actb2:myl12.1-mCherry*) to visualize non-cardiac myosin II[@R38], and *Tg(tbx5aBAC:eGFP)* (see below) were maintained at 28 ºC under standard conditions, and the embryos were staged as described previously[@R39]. Fertilized hen eggs were purchased from Granja Gilbert (Tarragona, Spain) and incubated in a humidified incubator at 37.5 ºC. Chick embryos were staged according to Hamburger and Hamilton[@R40] (HH) or somite number. Normal mouse embryos were obtained from natural matings of C57BL/6J mice. The age of mouse embryos was determined as days postcoitum (dpc), and by somite number. *Snai1^tm1.1Stjw^; Tg(UBC-cre/ERT2)^1Ejb^*; *Gt(ROSA)26Sor^tm14(CAG-tdTomato)Hze^* \[*Snail1^flox^*^/flox41^ Ubiquitin-driven cre/ERT2[@R42]; tdTomato cre reporter[@R43]\] embryos were obtained from pregnant females that were gavage fed 250 µl of 30 mg/ml Tamoxifen dissolved in 5% Ethanol in corn oil (Sigma) at 6.5 dpc. Embryos were obtained at 8.5 dpc. This combined genotype allows circumventing the early lethality caused by the loss of function of Snail1 before gastrulation[@R44]. *UBC-cre/ERT2* provides a temporal control of CRE activity, the presence of Tamoxifen at 6.5 dpc allows CRE activity after gastrulation in all the cells of the embryo. Tamoxifen induced Cre activity was monitored by the presence of tdTomato fluorescence. An additional *Snail1* conditional mutant model in which deletion was driven by the Meox-Cre line (*Snail1* deleted in embryonic tissues from around 8dpc) has been used previously[@R4]. In both conditional models, Snail1 is deleted after early gastrulation and early L/R determination, and coinciding with the time when Snail1 is transiently expressed in a L/R asymmetric manner in the LPM[@R45]. Both models show heart laterality defects and our data in provide the cellular and molecular mechanism that explains this phenotype.

All animal studies were performed without randomization to form the experimental groups. Sample size was not predefined for experiments involving embryos. For ChIP experiments 5 biological replicates where done, Luciferase experiments were done on primary fibroblast using 4 biological replicates. No blinding was used in the experimental design; however, results were independently scored by two people. No particular selection of sex of the animals was performed since in all cases the embryos were younger than the sex determination stage. All the experimental animals used here were at embryonic stages.

All animal procedures were conducted in strict compliance with the European Community Council Directive (2010/63/EU) and Spanish legislation. The protocols were approved by the CSIC Ethical Committee and the Animal Welfare Committee at the Institute of Neurosciences.

Generation of the *Tg(tbx5aBAC:eGFP)* transgenic line {#S3}
-----------------------------------------------------

The bacterial artificial chromosome (BAC) containing the zebrafish *tbx5a* gene (CH73-99A14) was obtained from the BACPAC Resources Center. A GFP-polyA cassette was introduced into the *zftbx5a*-containing BAC by homologous recombination[@R46]. Briefly, a 588 bp 5' homology arm encompassing part of the *zftbx5a* first intron and the 5'UTR of the second exon, as well as a 479 bp 3' arm starting at the ATG of the *tbx5a* gene present in its second exon, were cloned into the PL451 vector (kindly provided by Dr Neal G. Copeland). The resulting targeting construct was electroporated into EL250 cells containing the CH73-99A14 BAC in order to enable homologous recombination and incorporation of the GFP-polyA cassette into the endogenous *tbx5a* ATG contained in the BAC. Homologous recombination was confirmed by sequencing the PCR fragments obtained with primers external to the targeting construct. The primer sequences used for both construction of the targeting construct and to confirm homologous recombination are available upon request. The NucleoBond BAC 100 Kit (MACHEREY-NAGEL) was used to obtain BAC DNA, and 1 nl of the 70 ng/μl BAC DNA was injected into the blastodisc of fertilized eggs, allowing the embryos to develop thereafter. On reaching sexual maturity, F0 fish were individually crossed to wild-type fish and EGFP^+^ F1 embryos were raised to adulthood to create the stable *Tg*(*tbx5a:eGFP)* transgenic line used herein. The analysis of the *Tg*(*tbx5a:eGFP)* reporter was carried out taking advantage of the native expression of GFP in all the time-lapse experiments. When the reporter was combined with immunofluorescence (i. e. [Fig 2g](#F2){ref-type="fig"} and [Extended Data Figs. 3](#F8){ref-type="fig"} and [4](#F9){ref-type="fig"}), eGFP detection was performed with an anti-GFP antibody to ensure a correct detection of the reporter expression.

Morpholinos and mRNA Injections {#S4}
-------------------------------

All antisense morpholino oligonucleotides were obtained from Gene Tools LLC and used as described elsewhere[@R47]. To interfere with endogenous expression, one-cell zebrafish embryos were injected with 4 ng of a previously published *prrx1a*^MO1^ splice site blocking morpholino or with 10 ng of the 5' UTR *prrx1a*^MO2^ morpholino, (both with proven efficiency and specificity[@R10]), with 5 ng of a *spaw* morpholino[@R18], with 2 or 4 ng of a *snail1b*^MO^ splice site blocking morpholino. Sequences in [Supplementary table II](#SD2){ref-type="supplementary-material"}. The dose for *snail1b*^MO^ was chosen after testing its efficiency in preventing splicing. After injecting different amounts of *snail1b*^MO^, RNA was extracted from 48hpf embryos, and RT-PCR was performed with oligonucleotides in exons 1 and 2 (sequences in [supplementary table I](#SD2){ref-type="supplementary-material"}) that yield a fragment of 100 bp ([Extended Data Fig. 9g](#F14){ref-type="fig"}). The standard control morpholino from Gene Tools was used in control injections. Capped nlsKaede[@R48] and LifeAct-GFP/LifeAct-RFP[@R49] mRNA were synthesized with the SP6 mMessage mMachine kit (Ambion), and 75 and 100 pg was injected into one-cell embryos, respectively.

Electroporation of siRNAs, morpholinos and vectors {#S5}
--------------------------------------------------

Chick embryo explants (stage HH3-4) were placed ventral side up on filter paper rings and electroporated with selected plasmids, siRNAs or morpholinos as described previously[@R50]. Unilateral and bilateral electroporations were performed as follows: For unilateral electroporation embryos were injected with plasmid and/or siRNA into the left or right half sides and the positive platinum electrode was placed parallel to the primitive streak onto the samples. To electroporate the whole population of cardiomyocyte precursors (bilateral electroporation), the positive platinum electrode was placed transverse to the primitive streak after the sample injection. Electroporations were performed bilaterally except for the experiments shown in [Fig. 3d, e](#F3){ref-type="fig"}, [Fig. 4b](#F4){ref-type="fig"}, and [Extended Data Fig 8g](#F13){ref-type="fig"} that were unilateral, left (L) or right (R). Gain of function experiments were performed by unilateral electroporation ([Fig. 3e](#F3){ref-type="fig"}). pMT-cNodal[@R51], a generous gift from Claudio Stern (UCL, UK) was used at 4 µg/µl ([Fig. 4b](#F4){ref-type="fig"}). The previously described pCX-*Prrx1* vector (1µg/µl)[@R10] or the pMT or pCX empty vectors (for control embryos) were combined with pCX-eGFP plasmid (0.5 µg/µl) to follow electroporation. Loss of function experiments were performed by unilateral or bilateral electroporation as indicated. Two siRNA for Prrx1 were designed (See [Supplementary table II](#SD2){ref-type="supplementary-material"} for sequences). A mix of these siRNAs (2µM each), plus the pCX-eGFP plasmid (0.5 µg/µl) and 6% sucrose was injected. Control embryos were electroporated with a scrambled siRNA. To interfere with the *Snail1* expression two splice site blocking fluorescein labelled morpholinos were designed (*Snail1*^MO1^ and *Snail1*^MO2^ Sequences in [Supplementary table II](#SD2){ref-type="supplementary-material"}) and a mix of these two morpholinos (1mM each) electroporated alone or in combination with the two siRNA for Prrx1 and pCX-RFP as a control for electroporation. The standard control fluorescein labelled morpholino from Gene Tools was used as a control. *Snail1* MOs efficiency in preventing splicing was tested by RT-PCR as described above. Oligonucleotides in exons 1 and 2 for *Snail1*^MO1^ that yield a fragment of 255 bp, and in exon 2 and 3 for *Snail1*^MO2^ that yield fragments 288 bp were used. The unspliced fragments are 950 and 1244 respectively.

CRISPR-Cas9 {#S6}
-----------

Cas9-NLS-6xHis (pET-28b-Cas9-His; Addgene \# 47327[@R52], was expressed in *E. coli*, purified on a Ni-column and stored at -20 ºC in 300mM NaCl, 10 mM Tris-HCl, 0.1 mM EDTA, 1 mM DTT and 50% Glycerol pH 7.4 at 25 ºC. For sgRNA production, oligos were obtained from Sigma and cloned in *Bsa* I digested DR274 (Addgene \#42250)[@R53]. The primer sequences are listed in [Supplementary table II](#SD2){ref-type="supplementary-material"}. The sgRNA was synthesized using MEGAshortscript™ T7 (Ambion) and purified with the MEGAclear™ kit (Ambion). For RNP formation and injection into one-cell zebrafish embryos, Cas9 (800 ng/µl) was incubated for 5 minutes at 37 ºC with equimolar amounts of *in vitro* transcribed gRNAs in the presence of 150 mM KCl. RNPs were injected into one-cell embryos. To perform T7 endonuclease test, DNA extracted from 24 hpf embryos was used to amplify a fragment containing the target region of *prrx1a*. After PCR, the amplicon was denatured and allowed to anneal. Digestion was performed with T7 Endonuclease I (New England Biolabs) according to the manufacturer's instructions. Heart situs and presence of mutations was determined in 89 embryos. The tail of each embryo was used to individually extract DNA and perform a T7 endonuclease test. The rest of the embryo was fixed and used for *in situ* hybridization with *myl7* to determine heart situs. Ratio of mesocardia in crispant was 54% (n=48/89) that is very similar to that of the *prrx1^MO^* morphants 49% (n=80/164) ([Extended Data Fig. 1d-f](#F6){ref-type="fig"}). Analysis of the CRiSPR- induced mutations was performed by amplification of the exon1 region and subsequent cloning and sequencing of the products. We detected mutations in all the embryos, the nature of the mutations was diverse and in all cases consistent with NHEJ repair of the resulting cuts produced around the location of the guides.

Pharmacological treatments {#S7}
--------------------------

Zebrafish embryos were treated from the 8 to 22 somite-stage with 0.02 mg/ml of human recombinant BMP4 protein (R&D Systems), Noggin (0.03 mg/ml; R&D Systems) or the Nodal inhibitor SB431542 (100 µM; Sigma). Embryos were also treated from 29 to 50 hpf with Blebbistatin (25µM; Sigma), while the control embryos received 0.1% DMSO alone. Before treatments the embryos were dechorionated to improve drug accessibility. Chick embryos were grown in easy culture as described elsewhere[@R54] and exposed to 1 ml of SB431542 (100 µM) from the 1 to 10 somite-stage or to 1ml of Blebbistatin (50 µM) from the 1 to 14 somite stage. After fixation, the embryos were processed for *in situ* hybridization. BMP4 (0.2 mg/ml) or Noggin (1 mg/ml) was loaded onto heparin acrylic beads by soaking the beads for 3h at room temperature. The beads were then placed into one side of the LPM at stage HH7 and the embryos were harvested 7 h later. Beads soaked in PBS were used as controls.

Whole-Mount *In Situ* Hybridization {#S8}
-----------------------------------

Whole-mount *in situ* hybridization using digoxigenin-labeled probes was performed on zebrafish, chick and mouse embryos[@R55]. Fluorescent *in situ* hybridizations were performed as described[@R56]. Probes for *zfprrx1a, zfcrestin zfitbp3, zfsnail1a, zfsnail1b, zfpitx2c, cPrrx1*[@R11]and *cPrrx2 were described previously*. Templates for *zfmyl7, zfamhc, zfvmhc, caMHC, cvMHC, cTbx5, cTbx18, cNkx2.5, cPalld, cPrrx2, mPrrx1* and *mPrrx2* were amplified by PCR from their respective cDNAs and subcloned into the pGEMT-easy vector (Promega) or pCDNA3 (Thermo Fisher) with the primers indicated in [Supplementary Table II](#SD2){ref-type="supplementary-material"} and used to generate probes. Some embryos were embedded in paraffin, gelatin or low melting temperature agarose and sectioned at 7, 40 or 150 μm respectively. For detail about probes see [Supplementary Table III](#SD2){ref-type="supplementary-material"}.

Anti-Prrx1 antibody generation {#S9}
------------------------------

To develop the rabbit polyclonal anti-Prrx1 antiserum, the N-terminus of axolotl (*Ambystoma mexicanum*) Prrx1 (amino acids 1-101) was cloned as a Glutathione S-Transferase (GST) and a Maltose Binding Protein (MBP) fusion protein. The GST-AxPrrx1-N and MBP-AxPrrx1-N fusion proteins were expressed in *E. coli* (BL21-DE3), and they were purified using Glutathione Sepharose 4B (GE) and amylose resin (New England Biolab), respectively. GST-AxPrrx1-N was injected into the rabbit to generate a polyclonal antiserum, which was affinity purified against MBP-AxPrrx1-N immobilized on a NHS-activated sepharose 4 Fast Flow column (GE). The antiserum was dialyzed and concentrated with Amicon Ultra-15 10K MWCO (Millipore) prior to use.

Immunofluorescence {#S10}
------------------

Whole mount embryos were fixed with 4% PFA overnight at 4 °C. After fixation, the embryos were dehydrated and rehydrated in graduated PBT (PBS + 0.1 % Tween 20):methanol series. Antigen retrieval was performed by maintaining the embryos for 15 min at 70 ºC in 150 mM Tris-HCl buffer (pH 9) and the embryos were permeabilised with cold acetone for 20 min at -20ºC. After washing with PBT, embryos were blocked with 10 % FBS for 3 hours at room temperature and incubated with the primary antibodies overnight at 4 °C. After washing for several hours in PBT, the embryos were incubated with the secondary antibodies overnight at 4 °C. Some embryos were embedded in gelatin or low melting temperature agarose and sectioned at 150 μm. For immunofluorescence on sections, embryos were embedded in paraffin and sectioned at 7 μm. Immunostaining was performed by standard procedures. Antigen retrieval was performed on the paraffin sections by incubation for 20 min at 100 ºC in Sodium Citrate Buffer (10 mM Sodium Citrate, 0.05% Tween 20, pH 6.0). Sections were incubated with the primary antibodies overnight at 4ºC and then incubated with the secondary antibodies for 1 hour at RT. Nuclei were counterstained with DAPI (4\',6-Diamidine-2\'-phenylindole dihydrochloride) by incubation of the samples in 1 µg/ml DAPI in PBT. Embryos were incubated overnight at 4 ºC and sections for 1 h at room temperature. Samples were washed extensively in PBT before mounting.

For antibody details, see [Supplementary Table I and III](#SD2){ref-type="supplementary-material"}.

Detection of actin and stress fibers {#S11}
------------------------------------

Detection of stress fibers and actin was performed using either TRITC or FITC conjugated Phalloidin. Fixed embryos were treated with a 1/50 dilution of labelled Phalloidin in PBT at 4 ºC overnight. After extensive washing in PBT, embryos or sections were directly analyzed in the confocal microscope. For life imaging of actin polymerization, GFP or RFP conjugated LifeAct[@R49] was used. Zebrafish one cell embryos were injected with mRNA encoding a GFP or RFP conjugated LifeAct and embryos were followed or fixed at the desired time. LifeAct was detected using an antibody against the conjugated fluorescent protein (GFP or RFP) in all cases in which the samples were previously fixed.

Semithin sections {#S12}
-----------------

Zebrafish embryos were fixed overnight at 4 ºC with 4% paraformaldehyde/2.5% glutaraldehyde in 0.1 M phosphate buffer (PB). After washing with PB, the embryos were post-fixed for 1 hour in the dark with 1% osmium tetroxide in PB at room temperature. After washing with PB, the embryos were dehydrated at 4 ºC through an acetone series (30%, 50%, 70%, 90%) followed by two washes in 100% acetone at room temperature. The embryos were embedded in Spurr\'s resin (EMS) following a progressive series of acetone:Spurr combinations: 1:1 overnight, 1:3 for eight hours, and pure resin overnight. On the next day, the embryos were transferred to fresh pure resin in flat molds, oriented and the blocks were polymerized at 70 ºC for 72 hours. Serial sections (500 nm) were obtained using a Histo diamond knife (Diatome), collecting every fifth section. The sections were placed on a deionized water drop on a glass slide using a steel loop, dried immediately at 90 ºC, stained with 30 μL of toluidine blue for 1 minute at the same temperature, washed with deionized water and dried for storage.

Microscopy and Image analysis {#S13}
-----------------------------

Different laser scanning confocal microscopes were used for image acquisition, including Leica TCS SP2, Leica TCS SP2 MP (Leica Microsystems GmbH) and Olympus FV1200 (Olympus). Whole-mount *in situ* images were taken using a Leica M125 dissecting scope and sections photographed using a Leica DMR microscope under Nomarski optics and equipped with a Leica DFC 7000T digital camera. *In situ* and immunofluorescence images were collected on an Olympus FV1200 microscope with a 20x objective (UPLSAPO 0.75NA dry) a 40x objective (UPLFLN 1.30 oil) and a 60x objective (PLAPON 1.40 oil). Different fluorophores were excited with the indicated laser lines as follows: DAPI at 405 nm, GFP, FITC and Alexa Fluor 488 at 488 nm, Cy3, RFP and Alexa Fluor 568 at 559 nm and Alexa Fluor 647 at 635 nm. DAPI was collected at 440-470 nm, GFP, FITC and Alexa Fluor 488 at 500-550 nm, Cy3, RFP and Alexa Fluor 568 at 570-620 nm and Alexa Fluor 647 at 650-700 nm. Time-lapse, Kaede photoconversion and laser ablation images were collected on a Leica TCS SP2 with a 20x objective (HC PL APO 0.7NA dry). Zebrafish actomyosin cable experiments were analysed using a confocal microscope Leica TCS SP8 with HyVolution with a 20x objective (HC PL APO CS2 0.75NA IMM) to improve the lateral resolution down to 140nm and to 300nm in the axial direction. This technique combines special acquisition settings (pinhole size 0.6 AU, hybrid detectors, step size between sections of 0.15 microns) and Huygens deconvolution in four different channels sequentially.

Raw data were analysed using Imaris software (Bitplane AG), to create 3D and 4D reconstructions of different views and for surface rendering. Single optical sectioning was used whenever possible, otherwise maximum intensity projection was used to generate images that contained enough information to be analyzed. Time-lapse movies were generated as Quick Time (.mov) format.

Quantification of the asymmetrical expression of Prrx1a {#S14}
-------------------------------------------------------

To identify Prrx1 positive cells in the LPM we took advantage of the *Tg(tbx5a:eGFP)* zebrafish line and the antibody against Prrx1. 22-somite transgenic embryos were fixed and subjected to double immunofluorescence against Prrx1 and GFP. Images were collected at a dorsal view and the images were analyzed using the Imaris software (Bitplane AG). Each individual cell was identified as single or double positive for the two markers. We developed a mask using ImageJ software (<https://imagej.nih.gov/ij/>).for all the double positive cells (Prrx1^+^, GFP^+^). The resulting nuclei were labelled with a yellow line in [Extended Data Fig. 3b](#F8){ref-type="fig"}. These cells were counted and a heat map of its levels is shown in the [Extended Data Fig. 3c](#F8){ref-type="fig"}. Both the number of cells and the levels of Prrx1 protein are higher on the right hand side.

Time-Lapse imaging {#S15}
------------------

For whole embryo imaging, embryos were dechorionated, anesthetized with 0.02% tricaine (MS222; Sigma-Aldrich) and mounted in 3% methylcellulose on a glass-bottom 35 mm culture dish (MatTek) containing an imprinted pattern of 1% agarose to provide support. Confocal imaging of the *Tg(tbx5a:eGFP)* embryos was performed using an Spectral Confocal Microscope (Leica TCS SP2), acquiring z-stacks every 10 min (step-size of 5 µm up to 300 µm depth). During imaging, embryos were maintained in an incubation chamber heated to 28.5 °C.

Kaede Photoconversion {#S16}
---------------------

For cell tracing experiments embryos were injected with 75 pg of *in vitro* transcribed mRNA encoding the photoconvertible green-to-red fluorescent protein Kaede into one-cell stage. Embryos at 22 hpf were mounted as above for live imaging. Photoconversion of Kaede[@R49] was performed unilaterally at the defined region of interest (ROI) illuminating with a diode laser 405 nm (Radius 405nm, 50 mW, Coherent Inc. Santa Clara. CA. USA) at 11x optical zoom and 80% laser power during 10 s. Z-stacks of green and red florescence were acquired immediately before and after photoconversion. To avoid further exposure to UV light, embryos were incubated in the dark until 50 hpf when they were imaged again.

Laser ablation {#S17}
--------------

The *Tg*(*tbx5a:eGFP)* embryos were mounted at 26 hpf as described above for time-lapse imaging. Laser ablation was performed unilaterally with a two-photon laser (Femtosecond Mai Tai HP Ti: sapphire mode-locked laser system, Spectra Physics, Mountain View, CA, USA) integrated on a spectral confocal microscope (Leica TCS SP2 MP). Irradiation over the selected region of eGFP positive cells was performed using an optical zoom of 12x, laser wavelength of 800 nm and maximum laser power. Before and after laser ablation, z-stacks were taken and maximum projections were created in order to evaluate the damage of the targeted cells. Embryos were incubated at 28 °C and imaged again at 50 hpf to determine the post-ablation phenotype. Embryos were fixed in 4 % PFA and some of them were used to assess heart looping by *in situ* hybridization with the cardiac myosin light chain marker *myl7*.

Total RNA Extraction, cDNAs Isolation and RT-qPCR Analysis {#S18}
----------------------------------------------------------

Using the Illustra RNAspin Mini isolation kit (GE Healthcare 25-0500-70), total mRNA was extracted from pools of 10 zebrafish embryos at 48 hpf, from pools of 5 chick embryos at HH11 stage or from mouse embryos at stage 8.5 dpc. Reverse transcription of total RNA was performed using Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo Scientific), according to the manufacturer's guidelines. RT-qPCRs were performed in a Step One Plus machine (Applied Biosystems) using Fast SYBR Green Mastermix (Applied Biosystems). RNA expression levels were calculated using the comparative Ct method normalized to the internal control genes indicated below. The final results were expressed as the relative RNA levels, calculated with the 2^-(ΔΔCt)^ method. Data are represented as the mean±s.e.m. of at least three independent experiments with each point analysed in triplicate. The primers used are listed in [Supplementary Table II](#SD2){ref-type="supplementary-material"}.

Chromatin immunoprecipitation (ChIP) assay {#S19}
------------------------------------------

A pool of approximately 80 chick embryos at stage HH10 were hand dissected and the region between the atrioventricular channel and the 3^rd^ to 4^th^ somite was used for Chromatin purification. Tissue was crosslinked with 1% formaldehyde in PBS for 10 min at room temperature and subsequently quenched with 0.125 M glycine for 15 min. Embryos were washed in cool PBS and resuspended in 300 µl of lysis buffer (1% SDS, 10mM EDTA, 50mM Tris-HCl pH8 and Protease inhibitor cocktail), followed by 15 min incubation on ice. Lysates were sonicated three times for 15 minutes in a Bioruptor (Diagenode) (H, 30 s on / 30 s off on ice). Sonicated lysates were diluted to 5 ml with dilution solution (0.01% SDS, 1% Tx100, 2mM EDTA, 20mM Tris-HCl pH 8, 150 mM NaCl, protease inhibitor cocktail), and used for antibody incubation. Antibodies (listed in the [Supplementary table I](#SD2){ref-type="supplementary-material"}) were added to the chromatin dilutions and incubated overnight with continuous rotation at 4°C. The chromatin-antibody mixes were added to overnight blocked Dynabeads-Protein A beads (Thermo Fisher) (Blocking solution is 0.05% BSA, 2 mg/ml salmon sperm DNA in dilution solution), and incubated for 4 hours with continuous rotation at 4°C. The beads were washed in four consecutive steps with wash buffers (WB) 1 to 4 using a magnetic concentrator (WB1: 0.1% SDS, 1% Triton X-100, 2mM Tris-HCl pH8 and 150 mM NaCl; WB2: 0.1% SDS, 1% Triton X-100, 2mM Tris-HCl pH8 and 500 mM NaCl; WB3: 1mM EDTA, 10mM Tris-HCl pH8, 1% Igepal (NP40), 1% sodium deoxycholate and 0.25M LiCl; WB4: 10mM Tris-HCl pH8 and 1mM EDTA). 10% Chelex was added to the beads, followed by vortexing and incubating at 95°C for 10 min. Proteinase K treatment (40 µg/ml in WB4) was performed by incubating at 55°C for 30 min with agitation followed by a 95°C incubation for 10 min with agitation. Samples were centrifuged at 13000 rpm for 2 min and the supernatant, which contains DNA, was used for qPCR assays with the primers indicated in [Supplementary Table II](#SD2){ref-type="supplementary-material"}.

Promoter activity assays {#S20}
------------------------

Distal and Proximal Smad containing regions were cloned from chick genomic DNA using the indicated primers. PCR fragments were cloned in the pGL3-Promoter vector (Promega). Mutagenesis was performed using the QuickChange Kit (Agilent) with the primers indicated in [Supplementary Table II](#SD2){ref-type="supplementary-material"}.

A pool of 5 chick embryos were collected after dissected at stage HH 35 to obtain embryonic fibroblast. Head, internal organs and bones were removed and the rest was minced with sterile scissors and digested with trypsin for 5 minutes at 37 C. Cells were pelleted and resuspended in DMEM supplemented with 5% FCS and 1% of penicillin/streptomycin. Fibroblasts were purified by their differential attachment to plates for 1 hour and posterior washing out of the other cell types. 24 hours later, 4×10^5^ cells/well were seeded and transfected with 20 ng of the pRL-TK control vector plus 100ng of either the *Prrx1* promoter fragments cloned in pGL3-promoter (Promega) or empty vector to be used in luciferase assays. Treatment with BMP4 (10ng/ml) was performed 24 h after transfection and lasted for 24 h. Cell lysates were harvested and Firefly and Renilla luciferase luminescence assays were performed using a Dual Luciferase Assay (Promega) as described by the manufacturer.

Statistical analysis {#S21}
--------------------

Statistical analysis was performed using the GraphPad Prism software package. Results were expressed as mean s.e.m. (standard error of mean). Differences among groups were tested by using two-tailed pair or unpaired Student's *t*-test or one-way ANOVA test, as indicated in figure legends. Differences were considered statistically significant when \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001.

Anatomical nomenclature {#S22}
-----------------------

We have used herein the term "posterior pole" to refer to the cardiac structures that are located at the caudal end of the developing heart in all the animal models. This term is equivalent to "venous pole" or "inflow tract" used by other authors. In the posterior pole, cells migrating from the posterior secondary heart field incorporate and contribute to part of the atrium and to all the sinus venosus (SV), the most posterior cardiac chamber. This process occurs in fish, chick and mouse. The main difference between the anatomical structures developing at the posterior pole of these models is the lack of *sinus venosus* horns in zebrafish embryos. In both chick and mouse, the *sinus venosus* comprises a central common chamber expanded at both sides by lateral horns (RSH and LSH) that are posteriorly continuous with the vitelline veins (VV). The myocardial/smooth muscle transition marks the limit between the sinus horns and the VV. The anterior or arterial pole of the zebrafish heart has been referred as outflow tract (OFT), since this is the usual term in the literature. We have used the term anterior intestinal portal (AIP) for the anterior invagination of the endoderm that gives rise to the foregut. Sinus horns and vitelline veins are successively located at the lateral margins of the AIP. The lateral plate mesoderm splits into somatic and splanchnic lateral mesodermal layers during the formation of the coelomic cavity. The somatic lateral mesoderm (SoLM) is in contact with the ectodermal cell layer. We have used the term dorsal splanchnic lateral mesoderm (DSpLM) to refer the mesodermal layer close to the invaginated foregut endoderm, and ventral splanchic lateral mesoderm (VSpLM) for the mesoderm in contact with the non-invaginated endoderm lateral to the AIP. This mesoderm contributes to the walls of the vitelline veins and the *sinus venosus* horns. A full list of abbreviations of anatomical structures is described in [Supplementary Table IV](#SD2){ref-type="supplementary-material"}.

Extended Data {#S23}
=============

![*prrx1a* downregulation induces heart looping defects.\
(**a**) Downregulation of *prrx1a* transcripts upon *prrx1a*^MO1^ microinjection. Data represent mean ± s.e.m. \*\*\* *p*\<0.001 by Student´s *t*-test (n= 3 biological replicates). (**b**) Microinjection of a *prrx1a*^MO2^ morpholino located in the 5´UTR also impairs normal heart looping at 50 hpf. Heart looping assessed by *in situ* hybridization with a *myl7* probe in embryos microinjected with control or *prrx1a*^MO2^ morpholino. The frequency of the phenotypes is indicated below the images. (**c**) Scheme of the *prrx1a* locus indicating its exon organization. The coding sequence is depicted in blue and the location of the guide RNAs (gRNAs) is indicated. The location of primers used for screening is indicated by the two coloured arrows. (**d**) Representative images of "crispants" obtained by injection of the indicated gRNAs and Cas9. The frequency of the phenotypes is indicated below the images. (**e**) Representative T7 endonuclease assays of 4 embryos per phenotype indicated in (d) and two wild type embryos (WT) used as negative controls. (**f**) T7 Endonuclease assay of 8 crispants and one WT embryo after injection of the indicated gRNAs. (**g**) The PCR products obtained from embryos 1, 2 and 5 in (f) were cloned and sequenced. Representative sequences of those embryos (embryo number indicated on the right), with the mutations indicated in red and the deletions with hyphens. The location of the gRNAs is indicated in green and the corresponding adjacent PAM in blue. Scale bars, 100 µm](emss-73274-f006){#F6}

![Cardiac phenotype of *prrx1a* morphant embryos.\
(**a**) Bright-field images in whole mount and Hematoxylin/eosin staining in sagittal sections of control and *prrx1a* morphant embryos (n=5 embryos per condition). (**b**) Snapshots of surface rendering images of representative control and *prrx1a* morphant embryos hybridized with the atrial marker *amhc*. The graph represents the area of *amhc* expression (µm^2^; n=7 per condition). Scale bar 100 µm. Data represent mean ± s.e.m. \*\*\**p*\< 0.001. Student´s *t*-test. (**c**) Parasagittal semithin sections of control and morphant embryos (48hpf) obtained at the right (R), middle (M) and left (L) levels. The ventricle (V) is on the right and the *sinus venosus* (SV) is well developed in the control. However, the morphant has the ventricle aligned with the atrium (A), and lacks a SV in the cardiac posterior pole (PP). Outflow tract, OFT. (**d**) Ventral view of a maximum intensity projection and z-plane sections of confocal images (right) through the OFT showing the expression of the anterior SHF marker *latent TGF-β binding protein-3* (*ltbp3*), in control and *prrx1a* morphant zebrafish embryos. The cardiomyocytes are visualized by MF20 immunofluorescence. Scale bars 50 µm.](emss-73274-f007){#F7}

![Prrx1a expression in the early embryo.\
(**a**) Maximum intensity projection of confocal images showing Prrx1 expression in *Tg*(*tbx5a:eGFP*) embryos with DAPI staining of cell nuclei (blue). Prrx1 and *tbx5a* colocalize in the LPM (left image). The asymmetric L/R expression of Prrx1 in the right LPM is better seen in the single channel view (middle image) and the transverse sections at the level of the white dotted line (right panel). *tbx5a* is absent from the neural crest (NC) and the posterior LPM (PLPM). (**b**) Prrx1/*tbx5* colocalization (yellow) identifies the Prrx1*+* cardiac precursor population once the PHT has formed. Number of double-positive cells on the left and right halves of the LPM. Data represent mean ± s.e.m. \*\* *p*\<0.01 by Student´s *t*-test (n=6). (**c**) Heat map of Prrx1 expression levels in the LPM cells identified in (b). Color code is shown on the right. Intensity was measured in individual cells of the selected regions in the left and right LPM and an average intensity value was obtained per side. The plot shows the average value obtained in the right relative to that in the left LPM. Data represent mean ± s.e.m \* *p*\<0.05 by Student´s paired *t*-test (n=6). (**d**) Dorsal view of zebrafish embryos to visualize the expression of *prrx1a* and the pan-neural crest marker *crestin*. Colocalization of *prrx1a* and *crestin* identifies the *prrx1a+* neural crest cell population. *tbx5* is excluded from the neural crest. NT, neural tube.](emss-73274-f008){#F8}

![Prrx1 and Tbx5 co-localization in developing heart tissues.\
(**a**-**c**) Ventral views or sagittal sections showing more Prrx1^+^/*tbx5a^+^* cells in the visceral pericardium (P) in contact with the heart tube (HT) on the right side (arrowheads in high power panels in a and c). Prrx1 is absent from the HT. Boxes in (c) indicate the areas highlighted on the right. (**d**) Sagittal sections of a 48 hpf zebrafish embryo showing Prrx1 expression compared with the cardiomyocyte marker MF20, or the atrial marker S46. Scale bars, 50 µm. A, atrium; E, eye; PV, pericardial vesicle; SV, *sinus venosus*; V, ventricle.](emss-73274-f009){#F9}

![Cell movements during heart development in the zebrafish embryo.\
(**a**) Snapshots from time lapse analysis of *Tg(tbx5:eGFP)* control and *prrx1* morphant embryos at heart looping stages. (**b**) Randomization of cardiac jogging in *prrx1a* morphants. Representative images of control (Ctrol MO) and *prrx1a* morphant (*prrx1a*^MO1^) embryos hybridized with a myosin light-chain 7 (myl7) probe to assess heart tube jogging direction. Images are dorsal views with anterior to the top. Scale bar 100 μm. (**c**) Quantification of heart-jogging direction. A, atrium; PHT, primary heart tube; SV, *sinus venosus*; V, ventricle.](emss-73274-f010){#F10}

![Photoablation of mesodermal cells in the LPM.\
(**a, b**) Photoablation was performed at 26-27hpf on the left (a) or the right side (b). Ventral views with merged bright field and z-plane confocal images, before and after unilateral photoablation (Pa) of *tbx5:eGFP+* cells. The photoablated areas are located in the most anterior region of the LPM adjacent to the limit of the extraembryonic tissue. Higher power images of the photoablated areas in the right columns correspond to the boxed areas. (**c**) Analysis of heart situs at 50 hpf. Heart visualized after *myl7 in situ* hybridization in WT and left- or right-photoablated (Pa) embryos. Mesocardia only develops in embryos photoablated on the right-hand side. (**d**) Cartoon of a ventral view of a zebrafish embryo at 30-32hpf with a boxed area that corresponds to that in the high power confocal images shown in [Figure 2f and g](#F2){ref-type="fig"}. (**e**) Snapshots of actomyosin fibers, generated by the merged images extracted from a time lapse confocal microscopy in live control (left panels) and *prrx1a* morphant embryos (right panels) of the *Tg(tbx5a:eGFP)* reporter line injected with LifeAct (n=7 embryos per condition). (**f**) Snapshots from time lapse videos of *Tg(tbx5a:eGFP)* embryos treated with Blebbistatin or with the vehicle alone. Scale bars, 50 μm.](emss-73274-f011){#F11}

![Prrx1 expression in chick embryos.\
(**a**) Whole mount in situ hybridization in chick embryos showing the transient asymmetric expression of *Snail1* in the LPM. (**b**) Expression analysis by double fluorescence in situ hybridization of *Prrx1* and *Nkx2.5* or *Tbx5* in whole mount embryos. (**c**) Transverse sections showing *Prrx1* and N*kx2.5* or *Tbx5* expression at the levels indicated by dotted lines in (b). Boxes indicate the position of the corresponding higher power images. The arrowhead indicates the center of the posterior pole displaced to the left. (**d**) Dual fluorescent *in situ* hybridization with *Prrx1* and the atrial (*aMHC*) or ventricular (*vMHC*) myosins. High power images of transverse sections as indicated on the left showing the absence of myocardial *Prrx1* expression. (**e**) Downregulation of *Prrx1* transcription upon RNAi electroporation. Data represent mean ± s.e.m. \*\*\* *p*\<0.001 by Student´s *t*-test, (n= 3 biological replicates). (**f-h**) Quantification of heart situs from experiments shown in [Fig. 3c-d](#F3){ref-type="fig"}, respectively. (**i**) *aMHC* and *vMHC* in control embryos and in those electroporated with *Prrx1* RNAi. (**j**) Morphometric analysis of the atrium in chick embryos electroporated with Ctrol RNAi or *Prrx1* RNAi. The graph represents the area of *aMHC* expression (µm^2^; 7 embryos per condition). Data represent mean ± s.e.m. \*\*p \< 0.01, Student *t*-test. (**k**) Expression of *Fgf8*, required for OFT formation, is not altered by *Prrx1* downregulation. (**l**) Prrx1 and Islet1 coexpression in the lateral right *sinus venosus* horn (RSH) (arrows). Scale bars 100 μm except for (a), 500 μm, and high power images in (l), 10 μm. A, atrium; AIP; anterior intestinal portal; CF, cardiac folds; LPM, lateral plate mesoderm; L or R SH; left or right sinus horns; OFT, outflow tract; SH, *sinus venosus* horns; V, ventricle.](emss-73274-f012){#F12}

![*Prrx1* is essential in the posterior pole of the heart.\
(**a**) Double fluorescent in situ hybridization for *Tbx18* and *Prrx1* in chick embryos. (**b**) *Tbx18* downregulation in embryos electroporated with control or *Prrx1* RNAi. (**c**) Maximum intensity projection of dual fluorescent staining for Prrx1 and Phalloidin (a mycotoxin that stains actin stress fibers). Stars show area of asymmetry and colocalization. (**d**) Heart looping assessed by MF20 immunofluorescence in embryos treated with vehicle or Blebbistatin. (**e**) Maximum intensity projection showing the cells coexpressing *Palladin* and *Prrx1*. (**f**) *Palladin* is decreased upon *Prrx1* downregulation. Data represent mean ± s.e.m. of 4 pools (5 embryos each) of control and Prrx1 knockdown embryos. \* *p*\<0.05, \*\* *p*\<0.01 by Student *t*-test. (**g**) Visualization of electroporated areas in chick embryos shown in [Fig. 4b](#F4){ref-type="fig"}. Embryos were co-electroporated on the right side with an *eGFP* reporter construct plus and empty vector or one containing the *Nodal* coding sequence. (**h**) Heart *situs* in embryos containing BSA- or BMP4-loaded beads. (**i**) Diagram of *Prrx1* promoter. Proximal (P) and distal (D) binding sites for Smad1/5/8 and constructs used in (j and k). (**j**) Chromatin immunoprecipitation with antibodies against Smad5 or IgG (negative control). Data represent mean ± s.e.m. \*\* *p*\<0.01, \*\*\* *p*\<0.001, ns (not significant) by Student *t*-test (n=5 biological replicates). (**k**) Luciferase activity of *Prrx1* promoter. Both distal (D) and proximal (P) Smad5 binding sites are functional. Fragments containing these sites can activate the promoter in primary chick fibroblasts upon BMP4 treatment. Mutations in those sites prevent the response to BMP4. Data represent mean ± s.e.m. \*\*\* *p*\<0.001, ns (not significant) by one way ANOVA (n=4 biological replicates). Dotted lines show the level of the sections. Scale bars 100 μm except for the high power images shown in (a), (b) and (e), which correspond to 10 μm. A, atrium; AIP; anterior intestinal portal; CF, cardiac folds; LPM, lateral plate mesoderm; L or R SH; left or right sinus horns; OFT, outflow tract; SV, *sinus venosus*; V, ventricle; VV, vitelline veins.](emss-73274-f013){#F13}

![*Snail* and *Prrx* in heart looping in vertebrate embryos.\
(**a**) *Prrx1* and *Snail1* expression in whole mount and transverse sections in chick embryos. (**b**) Maximum intensity projection of confocal images showing heart situs by triple immunofluorescence in embryos electroporated with control fluorescein-labelled morpholinos, with a mix of two fluorescein-morpholinos against *Snail1* or a combination of *Snail1* morpholinos plus *Prrx1* RNAi. An RFP construct was used as a reporter of the electroporated cells. (**c**) Schematic drawing and knockdown efficiency assay of the *Snail1* splice fluo-morpholinos. (**d**) Quantitative analysis of heart *situs*. *(***e***) snail1a* is not expressed in the LPM in zebrafish embryos. (**f**) *snail1b* expression in whole mounted and transverse sections at the levels of the dotted lines. (**g**) Schematic drawing and knockdown efficiency assay of the *snail1b* splicing site morpholino (*snail1b*^MO^). (**h**) Quantification of heart *situs* in control and *snail1b* morphants. (**i**) *snail1b* is not expressed in the pericardium (P) in the zebrafish embryo. Scale Bars 100 μm except for the whole mount in (a) and section shown in (i), which correspond to 500 and 50 μm, respectively.](emss-73274-f014){#F14}

![Model for heart looping in vertebrates.\
(**a**) Cartoon depicting the comparative expression of Prrx1 and Snail1 in zebrafish, chick and mouse embryos. (**b**) Transverse sections showing the lack of *Prrx2* expression in the SH of chick or mouse embryos at HH9-10 and 8.5dpc stages, respectively. Scale bar 100 μm. (**c**) Schematic representation of the proposed model for heart looping in vertebrates in relation to the expression of *Prrx1* and *Snail1*. (**d**) A prominent right-handed pathway drives differential L/R EMT and heart looping in vertebrates. In addition to the left-specific Nodal-Pitx2 pathway that confers left identity and represses the right-handed pathway, BMP signalling activates EMT in the LPM in a L/R asymmetric manner to drive heart laterality and the repression of leftward information on the right through the repression of Pitx2. This conserved cellular mechanism is implemented through the activation of different EMT inducers in different vertebrates. A, atrium; AIP, anterior intestinal portal; C, coelom; DSpLM, dorsal splanchnic lateral mesoderm; Ec, ectoderm; FG, foregut; LA, left atrium; LSH, left sinus horn; LV, left ventricle; LVV, left vitelline vein; NC, neural crest; N, notochord; NP, neural plate; NT, neural tube; OFT, outflow tract; PV, pericardial vesicle; RA, right atrium; RSH, right sinus horn; RV, right ventricle; RVV, right vitelline vein; SoLM, somatic lateral mesoderm; S, somite; SV, sinus venosus; V, ventricle; VSpLM, ventral splanchnic lateral mesoderm; YS, yolk sac.](emss-73274-f015){#F15}
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![*prrx1a* L/R asymmetric expression.\
(**a**) Whole mount in situ hybridization and transverse sections at the levels of the dotted lines. **b**) Heart situs in control and *prrx1a* morphant (*prrx1a*^MO1^) embryos analyzed with the cardiomyocyte marker *myl7*. (**c**) Quantification of heart situs. (**d**) Analysis of atrial (A) and ventricular (V) markers *amhc* and *vmhc*. (**e**) Confocal analysis of Prrx1 and Islet1 expression in transgenic zebrafish embryos *Tg*(t*bx5a:eGFP*). Nuclei stained with DAPI. Stars, areas of asymmetry. Scale bars, 50 µm except for high power images in (e), 10µm.](emss-73274-f001){#F1}

![Asymmetric L/R Prrx1a expression drives heart looping in zebrafish.\
(**a**) Cell lineage tracing, n=4. The heart tube is revealed by MF20 immunostaining. (**b**) Snapshots extracted from videos of control and *prrx1a* morphant *Tg(tbx5a:eGFP)* embryos. Red and magenta represent right and left cardiomyocyte precursors. (**c**) Prrx1 expression in a LifeAct injected *Tg(actb2:myl12.1-mCherry)* embryo to visualize F-actin and myosin II, respectively. Star, mesenchymal cell; arrows, epithelial cells. (**d**) Maximum intensity projection of a *Tg(tbx5a:eGFP)* embryo. Bracket highlights the "cable-like" structure. (**e**) Photoablation (Pa) in *Tg(tbx5a:eGFP)* embryos. Ventricles (V) and atria (A) are shown in transverse sections on the right. (**f**) High resolution images of the "cable-like" structure analyzed as in (c). (**g**) *Palladin* (*Palld*), Prrx1 and *tbx5a* expression in control and *prrx1a* morphant embryos. Scale bars 50 µm except for (c) and high power images in (a, f and g), 10 µm. P, pericardium.](emss-73274-f002){#F2}

![Prrx1 also drives heart looping in the chick embryo.\
(**a-b**) *Prrx1* expression in whole embryos and transverse sections. (**c**) Bilateral (B) electroporation with an *eGFP* reporter construct plus either RNAi against *Prrx1* or control RNAi. (**d-e**) Unilateral electroporation (left, L) with control or *Prrx1 RNAi* vector (d) or with a vector containing the *Prrx1*-coding sequence (e). (**f**) Immunofluorescence of Islet1 and Prrx1 in control and *Prrx1* RNAi electroporated embryos. (**g**) *Palladin* expression in similarly treated embryos. Stars, areas of asymmetry. Nuclei were stained with DAPI (blue). Dotted lines indicate the level of the sections shown. Scale bars, all 250 μm except for the high power images in (f) and (g), which correspond to 50 μm. AIP; anterior intestinal portal; L or R SH; left or right *sinus venosus* horns; SoLM or SpLM, somatic or splanchnic lateral mesoderm.](emss-73274-f003){#F3}

![Two parallel and mutually exclusive pathways integrate left and right information.\
(**a**) *Prrx1* expression in chick embryos treated with BSA-(Ctrol), BMP4- or Noggin-soaked beads.(**b**) Embryos electroporated on the right with a vector containing the *Nodal* coding sequence. (**c**) Embryos treated with Nodal inhibitor alone or in combination with a Noggin- soaked bead. (**d**) *prrx1a* expression in control zebrafish embryos and after treatment with BMP4 or Noggin, or after Nodal inhibition (inhibitor or *spaw*^MO^ microinjection). (**e**) The parallel Nodal and BMP pathways during heart looping. Scale bars 250 μm.](emss-73274-f004){#F4}

![A differential L/R EMT drives heart positioning in vertebrates.\
(**a**) *Prrx1* and *Snail1* expression in chick embryos (9-10 somite stage) at two levels of the posterior pole of the heart. (**b**) *pitx2c* expression in control and *prrx1a* morphant zebrafish embryos. (**c**) Similar analysis to that shown in (a) in mouse embryos (8.5 dpc). (**d**) Whole mount and transverse sections of 8.5 dpc mouse embryos showing Phalloidin staining and *Snail1* expression. (**e**) *Snail1* mutant cells visualized as tdTomato+ (red) cells and actin fibers (Phalloidin). (**f**) *Palladin* expression upon *Snail1* depletion (KO). Data represent mean ± s.e.m. \*\* *p*\<0.01, \*\*\* *p*\<0.001 by Student *t*-test (n=6 per condition). (**g**) Proposed model for heart looping in vertebrates. Scale bars 100 µm except for the high powers in (d) and (e) 25 µm.](emss-73274-f005){#F5}
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